NCT05980416 Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 Status TERMINATED Phase PHASE1
NCT05980000 Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05978713 A Study of Tirzepatide (LY3298176) in Healthy Lactating Females Status COMPLETED Phase PHASE1
NCT05974579 Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT05971940 A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone Status COMPLETED Phase PHASE3
NCT05963022 A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) Status COMPLETED Phase PHASE3
NCT05960851 A Study of LY3871801 in Healthy Asian and Non-Asian Participants Status COMPLETED Phase PHASE1
NCT05959109 A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT05959096 A Study of LY3437943 in Healthy Participants With a High Body Mass Index Status COMPLETED Phase PHASE1
NCT05936151 A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT05936138 A Study of LY3502970 in Participants With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT05932446 A Study to Compare Two Formulations of LY3819469 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05931380 A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease Status COMPLETED Phase PHASE3
NCT05931367 A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee Status COMPLETED Phase PHASE3
NCT05929079 A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05929066 A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05916560 A Study of LY3437943 in Participants With Impaired and Normal Liver Function Status COMPLETED Phase PHASE1
NCT05914688 A Study to Compare Two Formulations of LY3209590 in Healthy Participants Status COMPLETED Phase PHASE1